Vaccines against Infectious Pathogens

Dear Colleagues,

As we know, through the development of better transportation, every region of the world has become increasingly interconnected. While it is beneficial, this increased interconnectivity has also led to a higher probability of disseminating infectious agents across different parts of the globe. In today’s world, no region is truly isolated, and infectious diseases that are endemic to any particular region have the propensity to be disseminated to another region. In this context, there can be no region that is less important than other regions when it comes to disease reporting and control. The recent pandemic is a clear indicator of the scale and seriousness of this issue. Keeping track of infectious diseases from any particular region through reliable reporting would help in planning and preparation for future outbreaks. Immunization through appropriate vaccines remains one of the best approaches to tackle the spread of communicable infectious agents and help mitigate the disease burden. However, not all disease outbreaks can be responded to with vaccines due to the lack of ideal vaccines. The lack of an ideal vaccine may be due to several reasons, such as the inherent properties of the pathogen that are a hurdle to the design of a suitable vaccine, the prevalence of the disease in a less economically strong country, and a lack of reliable disease reporting, which all lead to less research funding and fewer inputs for particular pathogens.

With these issues in mind, we are turning our attention and focus to all the “under-reported regions” of the globe, and encourage and welcome submissions of manuscripts on the following aspects:

1. Perspectives on lesser-known infectious diseases in any part of the globe that require attention and entail vaccine development.
2. Perspectives and reviews on human, veterinary and zoonotic diseases that have a high propensity to cause major outbreaks.
3. Case reports of regional emerging and re-emerging infectious diseases.
4. Regional vaccine efficacy studies.
5. Regional vaccine-related issues.
6. Development and improvement of current vaccines.

Dr. Jonathan Lalsiamthara
Dr. Junki Maruyama
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• regional disease reports
• vaccines
• zoonotic diseases
• emerging disease